Fig. 5

Reduced tumor uptake of (inactive) ¹⁸F-iC2Am versus (active) ¹⁸F-C2Am in MEDI3039-treated mice (0.4 mg/kg, 24 h, i.v.) bearing Colo205 tumors. Red lined triangles (¹⁸F-C2Am); black lined squares (¹⁸F-iC2Am)